Title |
Transcription Factor NF-κB: An Update on Intervention Strategies
|
---|---|
Published in |
Archivum Immunologiae et Therapiae Experimentalis, May 2016
|
DOI | 10.1007/s00005-016-0405-y |
Pubmed ID | |
Authors |
Arvind Panday, Maria Eugenia Inda, Prathyusha Bagam, Malaya K. Sahoo, Diana Osorio, Sanjay Batra |
Abstract |
The nuclear factor (NF)-κB family of transcription factors are ubiquitous and pleiotropic molecules that regulate the expression of more than 150 genes involved in a broad range of processes including inflammation, immunity, cell proliferation, differentiation, and survival. The chronic activation or dysregulation of NF-κB signaling is the central cause of pathogenesis in many disease conditions and, therefore, NF-κB is a major focus of therapeutic intervention. Because of this, understanding the relationship between NF-κB and the induction of various downstream signaling molecules is imperative. In this review, we provide an updated synopsis of the role of NF-κB in DNA repair and in various ailments including cardiovascular diseases, HIV infection, asthma, herpes simplex virus infection, chronic obstructive pulmonary disease, and cancer. Furthermore, we also discuss the specific targets for selective inhibitors and future therapeutic strategies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 94 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 17% |
Researcher | 15 | 16% |
Student > Ph. D. Student | 14 | 15% |
Student > Bachelor | 13 | 14% |
Student > Doctoral Student | 10 | 11% |
Other | 10 | 11% |
Unknown | 16 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 23% |
Biochemistry, Genetics and Molecular Biology | 20 | 21% |
Agricultural and Biological Sciences | 9 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Immunology and Microbiology | 4 | 4% |
Other | 10 | 11% |
Unknown | 24 | 26% |